NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling

NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types

NeoGenomics to Participate in Upcoming Investor Conferences

  • NeoLINK Login
  • Investors
  • Contact Us
Search
LogoNeoLINK Login
Menu
  • Home
  • Providers
    Providers
    • Oncology solutions
      • RaDaR ST MRD
      • PanTracer portfolio
      • Lung cancer
      • Breast cancer
      • Colorectal cancer
      • Gastric cancer
      • Gynecologic cancer
      • Hematologic cancers
    • Pathology solutions
      • Test search
      • Lab services
    • Client support & resources
      • EHR Capabilities
      • Certifications & licenses
      • Test requisition forms
      • Pathline clients
  • Partners
    Partners
    • Biopharma services
    • RaDaR ST for Pharma Partners
    • Oncology data solutions
    • Regulatory support
  • Patients
  • About NeoGenomics
    About NeoGenomics
    • Who we are
    • Scientific contributions
    • Oncology view
    • Careers
    • Privacy
    • Contact us
  • Billing
    Billing
    • For clinicians
    • For patients
    • Financial assistance
    • Pay your bill online
  • Test Search
  • Investors
Test Search
Skip to main content Skip to section navigation Skip to footer
NeoGenomics, Inc. IR Overview
  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Presentations
    • Literature
    • Email Alerts
  • Company Info
    • Overview
    • Executive Team
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Info
    • Quote
    • Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • CSR
    • 2025 report
    • Inaugural Report

IR Calendar

Investors News & Events IR Calendar
Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Presentations
    • Literature
    • Email Alerts
  • Company Info
    • Overview
    • Executive Team
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Info
    • Quote
    • Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • CSR
    • 2025 report
    • Inaugural Report

  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Presentations
  • Literature
  • Email Alerts

Second Quarter 2024 Financial Results Conference Call

Jul 29, 2024 4:30 pm EDT
Earnings ReleaseHTML
Earnings WebcastAudio
PresentationPDF
10-QHTML XBRL Zip
  • emailEmail Alerts
  • location_cityCompany Profile
  • rss_feedRSS News Feed
  • account_treeSitemap
©2026 NeoGenomics, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement
  • Manage Cookie Preferences